VJOncology is committed to improving our service to you

ASCO 2020 | Intrathecal + IV nivo for metastatic melanoma with leptomeningeal disease

VJOncology is committed to improving our service to you

Sunandana Chandra

Sunandana Chandra, MD, MS, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL, reviews data from a single-center Phase I/Ib study of concurrent intrathecal and intravenous nivolumab for patients with metastatic melanoma with leptomeningeal disease. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter